AvenCell Japan, a wholly-owned subsidiary of AvenCell Therapeutics, has received up to $40 million in funding from the Japan Agency for Medical Research and Development (AMED). The non-dilutive capital supports the global development of the AVC203 candidate, an IND-phase allogeneic CAR-T therapy targeting CD19 and CD20 antigens, being developed for the treatment of B-cell lymphomas. AvenCell's proprietary technology uses multi-stage gene editing to prevent rejection of donor cells by the patient's immune system without compromising T-cell efficacy. Early clinical data from the AVC201 program for patients with relapsed and refractory acute myeloid leukemia (AML) show that the allogeneic cells expand robustly and remain active beyond the usual one-month rejection limit – a breakthrough compared to previous allogeneic approaches. The funding underscores the significance of AvenCell's approach in an area of high medical… 

Cremation has long been the standard in Germany: over 50 percent of deceased individuals are cremated, and the number is rising. But behind the quiet work of the approximately 200 crematoria, an issue rarely comes to light is simmering: What happens to the dental gold and other precious metals left behind after cremation? Estimates suggest up to one ton of gold, worth millions of euros, is generated annually – a treasure hidden in the furnaces of crematoria. While some facilities claim to donate the proceeds to charitable causes, reports of abuse, embezzlement, and lack of transparency are increasing. Private crematoria, such as the one in Braunschweig, are particularly coming under fire. This investigative report sheds light on the questionable practices in the industry, the unclear legal situation, and possible parallels to organized crime, which could range from systematic theft to illegal networks. A million-dollar business in the shadow of the… 

The Spanish pharmaceutical company ESTEVE has entered into an agreement with Sanofi to acquire the rights to Caprelsa® (vandetanib) in over 50 countries. The drug is used to treat aggressive and symptomatic medullary thyroid cancer in adults and children over five years of age. Medullary thyroid carcinoma, a rare neuroendocrine tumor, originates in calcitonin-producing cells of the thyroid gland. Caprelsa®, a tyrosine kinase inhibitor, blocks enzymes, reduces blood supply to cancer cells, and thus slows tumor growth. The acquisition marks another step in ESTEVE's international growth strategy, focusing on highly specialized therapies for rare diseases. In April 2024, ESTEVE already acquired a company specializing in endocrinology and onco-endocrinology, expanding its portfolio to include three drugs for endogenous Cushing's syndrome and adrenocortical carcinoma. Furthermore, ESTEVE recently secured a license for a biological product for the treatment of children and adolescents with severe primary deficiency of insulin-like… 

June 30, 2025 – The ongoing heatwave with temperatures exceeding 40 degrees Celsius presents a significant health challenge. Dehydration and electrolyte imbalances, in particular, threaten vulnerable populations. This report highlights the medical importance of electrolyte solutions, their physiological basis, and practical application under extreme heat conditions. Physiological Role of Electrolytes Electrolytes – particularly sodium, potassium, chloride, magnesium, and calcium – are central regulators of fluid balance, osmotic balance, and neuromuscular function. They enable nerve signal transmission, muscle contraction, and the maintenance of acid-base balance. In heat, the body loses large amounts of water and electrolytes through excessive sweating, altering plasma concentrations of these ions. An imbalanced electrolyte state leads to symptoms such as muscle cramps, hypotension, arrhythmias, or, in extreme cases, heatstroke with multiple organ failure. Pathophysiology of Heat Stress High ambient temperatures increase the body's heat production and impair thermoregulation. Sweat loss can be substantial under intense heat…